Search results for "TC"

showing 10 items of 9993 documents

Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C.

2011

Background Genotype 1 (G1) chronic hepatitis C (CHC) patients achieving a rapid virological response (RVR) on pegylated interferon (PEG-IFN) plus ribavirin have a high chance of sustained virological response (SVR), influenced by IL28B status, viral load, fibrosis and insulin resistance. We assessed whether 25-hydroxyvitamin D (25[OH]D) serum levels are linked to RVR and can be used together with IL28B to construct a pretreatment model to predict RVR. Methods A total of 117 consecutive patients with G1 CHC were evaluated by biopsy and anthropometric and metabolic measurements. 25(OH)D serum levels were measured by HPLC. IL28B rs12979860 and rs8099917 polymorphisms were also evaluated. All p…

AdultMaleStandard of careGenotypeHepacivirusAntiviral AgentsPolymorphism Single NucleotidePolyethylene GlycolsVirological responsechemistry.chemical_compoundChronic hepatitisPegylated interferonRisk FactorsGenotypeVitamin D and neurologyMedicineHumansPharmacology (medical)Vitamin DPharmacologybusiness.industryRibavirinInterleukinsInterferon-alphaStandard of CareHepatitis C ChronicMiddle AgedViral LoadRecombinant ProteinsInfectious DiseasesTreatment OutcomechemistryImmunologyFemaleInterferonsbusinessmedicine.drugAntiviral therapy
researchProduct

The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome

1998

Abstract Background/Aims: To study whether the host's immune response determines viral clearance in chronic hepatitis C, virological markers and antigen-specific T cell reactions were analysed in 30 chronic HCV carriers followed up during interferon-α therapy, 11 untreated anti-HCV positive individuals and 10 healthy controls. Methods: Proliferative T helper cell responses to recombinant HCV core and non-structural antigens were monitored by 3 H-thymidine uptake assay and compared to quantitative viraemia levels and HCV genotypes. Results: Of the 30 treated patients, six had sustained complete responses (20%), another six were transient therapy responders (20%) and 18 were non-responders (6…

AdultMaleT-LymphocytesvirusesHepatitis C virusmedicine.medical_treatmentT cellAlpha interferonHepacivirusBiologyLymphocyte Activationmedicine.disease_causeInterferonmedicineHumansViremiaInterferon alfaAgedHepatologyInterferon-alphavirus diseasesImmunotherapyT helper cellHepatitis C ChronicMiddle AgedVirologyTreatment Outcomemedicine.anatomical_structureImmunologyRNA ViralFemaleHepatitis C AntigensViral loadFollow-Up Studiesmedicine.drugJournal of Hepatology
researchProduct

An Internet-Based Self-Help Treatment for Fear of Public Speaking: A Controlled Trial

2010

Abstract This study offers data about the efficacy of “Talk to Me,” an Internet-based telepsychology program for the treatment of fear of public speaking that includes the most active components in cognitive-behavior therapy (CBT) for social phobia (exposure and cognitive therapies). One hundred twenty-seven participants with social phobia were randomly assigned to three experimental conditions: (a) an Internet-based self-administered program; (b) the same program applied by a therapist; (c) a waiting-list control group. Results showed that both treatment conditions were equally efficacious. In addition, Talk to Me and the same treatment applied by a therapist were more efficacious than the…

AdultMaleTelemedicinePsychotherapistAdolescentSocial PsychologyMEDLINEbehavioral disciplines and activitieslaw.inventionSelf-helpYoung AdultRandomized controlled triallawmental disordersHumansSpeechYoung adultSocial BehaviorApplied PsychologyProgrammed Instructions as TopicAnalysis of VarianceInternetCognitive Behavioral Therapybusiness.industryCommunicationCognitionGeneral MedicineMiddle AgedTelemedicineComputer Science ApplicationsHuman-Computer InteractionSelf-Help GroupsPublic speakingTreatment OutcomePhobic DisordersTherapy Computer-AssistedThe InternetbusinessPsychologyFollow-Up StudiesClinical psychologyCyberpsychology, Behavior, and Social Networking
researchProduct

Piroxicam-induced photosensitivity and contact sensitivity to thiosalicylic acid

1990

A photocontact dermatitis developed in three patients after the application of gel containing 0.5% piroxicam. Patch tests were positive to thiomersal and thiosalicylic acid. Photopatch tests with piroxicam at several concentrations were positive in the three patients but negative in 62 normal volunteer subjects. Patch tests performed on 14 patients with proved systemic photosensitivity to piroxicam were positive for thiomersal and thiosalicylic acid. Nine of 12 patients previously sensitized to thiosalicylic acid and with no history of exposure to piroxicam showed positive photopatch test reactions to this chemical. These results support a relation between piroxicam-induced photosensitivity…

AdultMaleThiosalicylic acidmedicine.medical_specialtyDermatologyPiroxicamDermatitis ContactBenzoateschemistry.chemical_compoundPiroxicamPhotosensitivityMedicineHumansPhotosensitivity DisordersSulfhydryl CompoundsVolunteerbusiness.industryThimerosalPhotosensitivity reactionsPhotocontact DermatitisMiddle AgedPatch TestsContact sensitivityDermatologychemistryFemaleThiomersalbusinessGelsmedicine.drug
researchProduct

Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment

2022

Although splenectomy is still considered the most effective curative treatment for immune thrombocytopenia (ITP), its use has significantly declined in the last decade, especially since the approval of thrombopoietin receptor agonists (TPO-RAs). The main objective of the study was to determine whether splenectomy was still as effective nowadays, particularly for patients with failure to respond to TPO-RAs. Our secondary objective was to assess, among patients who relapsed after splenectomy, the pattern of response to treatments used before splenectomy. This multicentre retrospective study involved adults who underwent splenectomy for ITP in France from 2011 to 2020. Response status was defi…

AdultMaleThrombopoietin Receptor Agonistsmedicine.medical_specialtymedicine.medical_treatmentSplenectomy[SDV.CAN]Life Sciences [q-bio]/CancerGastroenterology[SDV.CAN] Life Sciences [q-bio]/CancerInternal medicineHumansMedicineRetrospective StudiesPurpura Thrombocytopenic Idiopathicbusiness.industryRetrospective cohort studyHematologyMiddle AgedImmune thrombocytopeniaTreatment OutcomeCurative treatmentSustained responseSplenectomyFemaleRituximabRituximabbusinessReceptors Thrombopoietinmedicine.drugAmerican Journal of Hematology
researchProduct

Peginterferon alfa-2b plus weight-based ribavirin for 24 weeks in patients with chronic hepatitis C virus genotype 1 with low viral load who achieve …

2012

. In chronic hepatitis C (CHC), treatment duration may be individualized according to time to first undetectable hepatitis C virus (HCV) RNA, with patients who attain undetectable HCV RNA early in treatment being candidates for shorter regimens. The aim of this study was to determine the relapse rate in patients with CHC genotype (G) 1 infection and low baseline viral load who achieved undetectable HCV RNA by week 4 [rapid virologic response (RVR)] when treated for 24 weeks. This was an open-label, multicentre, noninterventional study. Adult patients with G1 CHC infection and baseline viral load <600,000 IU/mL who attained RVR were treated with peginterferon alfa-2b (1.5 mu g/kg/week) plus …

AdultMaleTime FactorsAdolescentGenotyperibavirinHepacivirusInterferon alpha-2Antiviral AgentsPolyethylene GlycolsYoung AdultRecurrenceRibavirinHumanspeginterferonhepatitis C virus genotyperelapseInterferon-alphaHepatitis C ChronicMiddle AgedViral LoadRecombinant Proteinsviral loadTreatment OutcomeHCVFemale
researchProduct

Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.

2003

Abstract Thrombotic thrombocytopenic purpura (TTP) is an uncommon hematologic thrombotic disorder characterized by fever, hemorrhagic and neurologic signs. The advent of plasma exchange has dramatically improved the prognosis of this disease, which was once inevitably fatal. However, mortality rates remain significant. Antiplatelet drugs have been widely used in combination with plasma exchange. In this pilot study we investigated the effects of an adjunctive therapy consisting of the continuous, intravenous infusion of dipyridamole, a modality of administration that has not been previously tested in this setting. Sixteen untreated TTP patients, diagnosed consecutively at our clinic, receiv…

AdultMaleTime FactorsCombination therapyThrombotic thrombocytopenic purpuraPilot ProjectsMethylprednisolonelaw.inventionRandomized controlled trialRefractorylawRecurrencemedicineHumansPlateletIn patientProspective StudiesInfusions IntravenousPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryPlatelet CountMortality rateRemission InductionHematologyDipyridamoleMiddle Agedmedicine.diseaseCombined Modality TherapyDipyridamoleTreatment OutcomeAnesthesiaFemalebusinessPlatelet Aggregation Inhibitorsmedicine.drugTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
researchProduct

rTMS of the prefrontal cortex in the treatment of chronic migraine: a pilot study

2004

A recent fMRI study showed that dorsolateral prefrontal cortex (DLPFC) exerts an inhibitory control on pain pathways in humans. We investigated whether high-frequency rTMS over left DLPFC could ameliorate chronic migraine. Treatment consisted of 12 rTMS sessions, delivered in alternate days over left DLPFC. Sham rTMS was used as placebo. Eleven patients were randomly assigned to the rTMS (n=6) or to the placebo (n=5) treatment. Measures of attack frequency, headache index, number of abortive medications (outcome measures) were recorded in the month before, during and in the month after treatment. Subjects treated by rTMS showed a significant reduction of the outcome measures during and in t…

AdultMaleTime FactorsKindligMigraine DisordersPrefrontal CortexPilot ProjectsPlacebobehavioral disciplines and activitieslaw.inventionCentral nervous system diseaseMagneticsChronic MigraineDouble-Blind MethodRandomized controlled triallawmental disordersrTMSmedicineHumansPrefrontal cortexChronic migrainePsychiatric Status Rating ScalesAnalysis of VarianceHeadacheMigraine prophylaxiMiddle Agedmedicine.diseaseElectric StimulationClinical trialDorsolateral prefrontal cortexTreatment Outcomemedicine.anatomical_structurenervous systemNeurologyMigraineAnesthesiaCortico-lymbic sensitizationChronic DiseaseFemaleLeft dorsolateral prefrontal cortexNeurology (clinical)Psychologypsychological phenomena and processes
researchProduct

Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplant…

2001

We investigated whether a T cell-reduced allogeneic stem cell transplant (SCT) with minimal conditioning and subsequent donor lymphocyte infusions (DLI) could reduce the incidence and severity of GVHD while retaining stable engraftment. Five patients with hematological malignancies (three MM, one CLL, one Chediak-Higashi syndrome) were conditioned with TBI (200 cGy). One patient additionally received fludarabine (120 mg/m(2)). CsA and mofetyl-mycophenolate (MMF) were administered to prevent GVHD. All patients were grafted with >3 x 10(6)/kg highly purified CD34(+) cells together with 2 x 10(6)/kg CD3(+) cells (three patients) or 1 x 10(5)/kg CD3(+) cells (two patients). Quick hematopoietic …

AdultMaleTime FactorsLymphocyte TransfusionT-LymphocytesT cellLymphocyteChronic lymphocytic leukemiamedicine.medical_treatmentHematopoietic stem cell transplantationLymphocyte DepletionFatal OutcomemedicineHumansTransplantation HomologousTreatment FailureTransplantation ChimeraTransplantationbusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle AgedMycophenolic Acidmedicine.diseaseLeukemia Lymphocytic Chronic B-CellPeripheral stem cell transplantationFludarabineTransplantationmedicine.anatomical_structureHematologic NeoplasmsLymphocyte TransfusionImmunologyCyclosporineFemaleChediak-Higashi SyndromeMultiple MyelomabusinessImmunosuppressive AgentsVidarabineWhole-Body IrradiationFollow-Up Studiesmedicine.drugBone Marrow Transplantation
researchProduct

Do Stretch Durations Affect Muscle Mechanical and Neurophysiological Properties?

2016

International audience; The aim of the study was to determine whether stretching durations influence acute changes of mechanical and neurophysiological properties of plantar flexor muscles. Plantar flexors of 10 active males were stretched in passive conditions on an isokinetic dynamometer. Different durations of static stretching were tested in 5 randomly ordered experimental trials (1, 2, 3, 4 and 10×30-s). Fascicle stiffness index, evoked contractile properties and spinal excitability (Hmax/Mmax) were examined before (PRE), immediately after (POST0) and 5 min after (POST5) stretching. No stretch duration effect was recorded for any variable. Moreover, whatever the stretching duration, st…

AdultMaleTime FactorsM waveStiffness indexPhysical Therapy Sports Therapy and RehabilitationPlantar flexionStatic stretchingYoung Adult03 medical and health sciencesstiffness0302 clinical medicineMuscle Stretching Exercises[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicineHumansOrthopedics and Sports MedicineH reflexMuscle Skeletalsoleusdose-responseFootChemistry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]030229 sport sciencesAnatomyNeurophysiologyFascicleTorqueIsokinetic dynamometermedicine.symptomH-reflex030217 neurology & neurosurgeryMuscle ContractionMuscle contractionBiomedical engineering
researchProduct